PMID: 9647608Jul 1, 1998Paper

Ischemic preconditioning: exploring the paradox

Progress in Cardiovascular Diseases
K Przyklenk, R A Kloner

Abstract

Brief transient episodes of nonlethal myocardial ischemia protect or "precondition" the heart and render the myocardium resistant to a subsequent more sustained ischemic insult. The hallmark of this phenomenon--documented in virtually all species and experimental models evaluated to date in countless laboratories worldwide--is the profound reduction in infarct size seen in preconditioned groups versus time-matched controls. Efforts to identify the cellular mechanisms responsible for this paradoxical ischemia-induced cardioprotection, to expand the definition of ischemic preconditioning beyond infarct size reduction, and, perhaps most importantly, to evaluate the efficacy of preconditioning in disease models and in the clinical setting, are all topics of intensive ongoing investigation.

References

Feb 1, 1992·Circulation Research·G J Gross, J A Auchampach
May 1, 1992·Cardiovascular Research·A VeghJ R Parratt
May 1, 1992·Cardiovascular Research·Y ShizukudaH F Downey
Jun 1, 1992·Circulation·M OvizeR A Kloner
Jan 1, 1991·The Journal of Clinical Investigation·A A KnowltonC S Apstein
Apr 1, 1990·Circulation Research·R J SchottW Schaper
Aug 1, 1990·Circulation·G C LiB R Lucchesi
May 1, 1988·The American Journal of Cardiology·L A PierardH E Kulbertus
Sep 1, 1995·Journal of Cardiac Surgery·M C RobinsonE Stedje-Larsen
Jul 1, 1995·Journal of Cardiac Surgery·K Przyklenk, R A Kloner

❮ Previous
Next ❯

Citations

Sep 27, 2005·Microsurgery·Claudiu F MarianMihai Ionac
Jan 31, 2006·Journal of Physiology and Biochemistry·M G Marina PrendesA Varela
Apr 26, 2001·Journal of Physiology and Biochemistry·G TestoniE A Savino
Feb 4, 2010·Basic Research in Cardiology·W J FanAmanda Lochner
Jun 25, 2005·Journal of Thrombosis and Thrombolysis·Karin Przyklenk, Peter Whittaker
Oct 8, 2005·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Philipp MarkartIvar Friedrich
Nov 9, 2005·International Journal of Cardiology·Jose P S HenriquesFelix Zijlstra
Sep 11, 1999·The American Journal of Cardiology·P Théroux
Mar 20, 2003·The Annals of Thoracic Surgery·Ulrich SunderdiekJochen D Schipke
Sep 26, 2002·Mechanisms of Ageing and Development·Paige LongTom L Broderick
Apr 24, 2001·Pharmacology & Therapeutics·R ZucchiS Ronca-Testoni
Nov 13, 2001·Journal of the American College of Cardiology·K PrzyklenkP Whittaker
Apr 8, 2003·Journal of the American College of Cardiology·Karin Przyklenk, Gerd Heusch
Jun 23, 2001·Cardiovascular Surgery : Official Journal of the International Society for Cardiovascular Surgery·Z K WuS Kaukinen
Sep 15, 2001·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·I FriedrichJ Borgermann
May 29, 2002·Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology·Guohu LiKarin Przyklenk
Nov 3, 2005·Nature Clinical Practice. Cardiovascular Medicine·Shereif H Rezkalla, Robert A Kloner
Apr 10, 2002·Anaesthesia·N M AgnewG N Russell
Apr 27, 2002·Heart Disease·Boris Z SimkhovichRobert A Kloner
May 11, 2000·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·E W DicksonK Przyklenk
Jul 23, 1999·Annals of the New York Academy of Sciences·K PrzyklenkR A Kloner
May 26, 2005·Circulation Journal : Official Journal of the Japanese Circulation Society·Masami KosugeUNKNOWN Japanese Acute Coronary Syndrome Study (JACSS) Investigators
Aug 2, 2001·Biochemical and Biophysical Research Communications·C CsonkaP Ferdinandy
Nov 24, 2011·Interactive Cardiovascular and Thoracic Surgery·Efstratios ApostolakisNikolaos A Papakonstantinou
Jul 20, 2010·European Journal of Clinical Investigation·Arintaya PhrommintikulNipon Chattipakorn
Mar 30, 1999·The Journal of Thoracic and Cardiovascular Surgery·M S JahaniaR M Mentzer
Apr 3, 2012·Journal of Traditional Chinese Medicine = Chung I Tsa Chih Ying Wen Pan·Xiang-Hui HanJue-Feng Cai
May 17, 2005·British Journal of Pharmacology·Karin Przyklenk, Peter Whittaker
Sep 26, 2006·Journal of Thrombosis and Haemostasis : JTH·M D LindenK Przyklenk
Feb 24, 2001·Scandinavian Cardiovascular Journal : SCJ·Z K WuM R Tarkka
Sep 11, 2002·Archives of Physiology and Biochemistry·A VarelaE A Savino
Sep 11, 2008·Expert Opinion on Therapeutic Targets·Md Shenuarin BhuiyanKohji Fukunaga
Mar 18, 2000·The Journal of Surgical Research·T H Pohlman, J M Harlan
Nov 2, 2001·The Journal of Thoracic and Cardiovascular Surgery·Z K WuM R Tarkka

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.